Int. J. Mol. Sci. 2013, 14(5), 9037-9050; doi:10.3390/ijms14059037
Review

Role of Melatonin in Schizophrenia

1,2,* email and 3email
Received: 19 February 2013; in revised form: 9 April 2013 / Accepted: 10 April 2013 / Published: 25 April 2013
(This article belongs to the Special Issue Advances in the Research of Melatonin)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Schizophrenia is a chronic mental disease that disturbs several cognitive functions, such as memory, thought, perception and volition. Schizophrenia’s biological etiology is multifactorial and is still under investigation. Melatonin has been involved in schizophrenia since the first decades of the twentieth century. Research into melatonin regarding schizophrenia has followed two different approaches. The first approach is related to the use of melatonin as a biological marker. The second approach deals with the clinical applications of melatonin as a drug treatment. In this paper, both aspects of melatonin application are reviewed. Its clinical use in schizophrenia is emphasized.
Keywords: melatonin; schizophrenia; biological marker; therapeutic agent
PDF Full-text Download PDF Full-Text [195 KB, uploaded 19 June 2014 04:50 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Morera-Fumero, A.L.; Abreu-Gonzalez, P. Role of Melatonin in Schizophrenia. Int. J. Mol. Sci. 2013, 14, 9037-9050.

AMA Style

Morera-Fumero AL, Abreu-Gonzalez P. Role of Melatonin in Schizophrenia. International Journal of Molecular Sciences. 2013; 14(5):9037-9050.

Chicago/Turabian Style

Morera-Fumero, Armando L.; Abreu-Gonzalez, Pedro. 2013. "Role of Melatonin in Schizophrenia." Int. J. Mol. Sci. 14, no. 5: 9037-9050.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert